VistaPharm, FDA Wednesday, June 30, 2010 +0.20 Positive

FDA Approves METHADONE HYDROCHLORIDE — VistaPharm, LLC

VistaPharm, LLC received FDA approval on June 30, 2010, for the 10 mg and 40 mg tablets of Methadone Hydrochloride (ANDA090707) as a generic oral formulation. This clearance enhances market competition for the maintenance treatment opioid and is expected to provide more affordable access to the essential therapy.

View original filing at SEC.gov →
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.

Get real-time financial news in your trading bot or app

START FREE — 10,000 calls/day, no key needed